Community seroprevalence of COVID-19 in probable and possible cases at primary health care centres in Spain
- PMID: 32914857
- PMCID: PMC7797756
- DOI: 10.1093/fampra/cmaa096
Community seroprevalence of COVID-19 in probable and possible cases at primary health care centres in Spain
Abstract
Background: There is a scarcity of information about patients with mild or moderate symptoms during the coronavirus disease 2019 (COVID-19). This is especially true for those who attended and were followed up at primary care settings.
Objectives: We aim to measure the seroprevalence of antibodies against SARS-CoV-2 infection in a community sample of possible cases and among probable cases followed in primary care.
Methods: We selected a random sample of 600 individuals stratified by age groups from a total population of 19 899 individuals from a community area in Barcelona. We also invited all the patients that had been followed by General Practitioners (GPs). For both populations, we used COVID-19 rapid lateral flow immunoassays, which qualitatively assess the presence of patient-generated Immunoglobulins G (IgG) and Immunoglobulin M (IgM).
Results: Three hundred and eleven asymptomatic individuals from the randomly selected sample participated in the study. The mean age was 43.7 years [standard deviation (SD) = 21.79] and 55% were women. Seventeen individuals were seropositive for IgM and/or IgG, resulting in an overall prevalence of 5.47% (95% confidence interval = 3.44-8.58). Six hundred and thirty-four symptomatic patients were followed up by GPs. The mean age was 46.97 years (SD = 20.05) and 57.73% were women. Of these, 244 patients (38.49%) were seropositive. Results of the multivariate logistic regression analysis showed that the odds ratio for a positive test was significantly increased in patients who had fever, ageusia and contact with a patient diagnosed with COVID-19.
Conclusions: The seroprevalence of antibodies against SARS-CoV-2 among possible cases was lower than expected. Approximately, 40% of the symptomatic patients followed up by GPs during the peak months of the pandemic were positive.
Keywords: General practice; infectious diseases; practice management; primary care; public health; screening.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
References
-
- World Health Organization. Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV) https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-...) (accessed on 16 May 2020).
-
- World Health Organization. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19 https://www.who.int/dg/speeches/detail/whodirector-general-s-opening-rem... (accessed on 17 March 2020).
-
- Flaxman S, Mishra S, Gandy A et al. . Estimating the Number of Infections and the Impact of Nonpharmaceutical Interventions on COVID-19 in 11 European Countries. Imperial College London (30-03-2020), Medical Research Council (MRC), The Royal Society. doi: 10.25561/77731. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
